Dr. Richard Alan Silverman, MD Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: Hudson Valley Va, Rt 9a, Montrose, NY 10458 Phone: 914-737-4400 |
Mr. Pe Shein Wynn, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 2094 Albany Post Road, Montrose, NY 10548 Phone: 914-737-4400 Fax: 845-632-2940 |
Carole M Roc, M.D. Psychiatry & Neurology - Geriatric Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 2094 Albany Post Rd, Montrose, NY 10548 Phone: 914-737-4400 Fax: 914-788-4293 |
Iva Lesniak, D.O. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 2094 Albany Post Rd., Bld. 13, Rm 10, Montrose, NY 10548 Phone: 845-831-2000 |
Dr. Geetha Ramachandran, MD Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 2049 Albany Po, Vet Erans Adminstration Hudson Vall Hcs, Montrose, NY 10548 Phone: 845-831-2000 Fax: 845-838-5236 |
Sheldon Travin, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 2094 Albany Post Rd, Montrose, NY 10548 Phone: 914-737-4400 |
Coquilla Deborah Cross, MD Psychiatry & Neurology - Psychiatry Medicare: May Accept Medicare Assignments Practice Location: 2094 Albany Post Road, Mail Code116a, Hudson Valley Health Care System, Montrose, NY 10548 Phone: 914-737-4400 |
Deborah Marie Foglia, M.D. Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 2094 Albany Post Rd, Montrose, NY 10548 Phone: 914-737-4400 Fax: 914-788-4825 |
Dr. Kathleen Alice Fortner, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 100 Albany Post Rd, Va Hudson Valley Health Care System, Montrose, NY 10548 Phone: 914-737-4400 Fax: 914-788-4295 |
Dr. Kamalamma A Duvvi, MD Psychiatry & Neurology - Geriatric Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 2094 Albany Post Rd, Va Hvhcs, Montrose, NY 10548 Phone: 914-737-4400 Fax: 914-788-4304 |
Stephen L Rachlin, MD Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: Va Hudson Valley Hcs Route 9a, Montrose, NY 10548 Phone: 914-737-4400 Fax: 914-788-4268 |
Dr. Annamma K Augustine, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 2094 Albany Post Rd, Va Hudson Valley Health Care System, Montrose, NY 10548 Phone: 914-737-4400 |
Dr. Mahpara Sherjil Khan, M.D Psychiatry & Neurology - Child & Adolescent Psychiatry Medicare: Medicare Enrolled Practice Location: 2094 Albany Post Rd, Montrose, NY 10548 Phone: 914-737-4400 |
Dr. David Robert Levy, M.D. Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 2094 Albany Post Rd, Va Hospital, Montrose, NY 10548 Phone: 914-737-4400 Fax: 914-788-4285 |
News Archive
Scientists at Seattle Children's Research Institute have discovered an area of the brain that could control a person's motivation to exercise and participate in other rewarding activities - potentially leading to improved treatments for depression.
​Researchers from the Biological clues of the invasive and metastatic phenotype group of the Bellvitge Biomedical Research Institute (IDIBELL) led by Isabel Fabregat have discovered the relationship between the TGFb signalling pathways and CXCR4 in hepatocellular carcinoma (HCC) .
UT Southwestern Medical Center researchers seeking novel treatments for anemia found that giving acetate, the major component of household vinegar, to anemic mice stimulated the formation of new red blood cells.
Genes that control percentage of body fat are also responsible for circulating levels of testosterone in men, research published in the latest edition of Clinical Endocrinology shows. The research shows a 23% overlap between the genes that control testosterone and those that regulate body fat composition, suggesting that these two variables are partly controlled by the same set of genes.
Altair Therapeutics, Inc., a privately-held, biopharmaceutical company developing novel therapeutics for respiratory diseases, today announced the commencement of its IL-4 receptor alpha inhibitor bronchoprovocation trial. Study AIR645-CS2 is a phase 2, multi-center, randomized, double-blind, placebo-controlled study to assess the safety, tolerability, and efficacy of inhaled AIR645 in suppressing the asthmatic response in subjects with mild asthma. Results are expected in the third quarter of 2010.
› Verified 5 days ago